Sierra Leone vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Sierra Leone
100.0%
in 2024
Sur
82.0%
in 2024
Sierra Leone rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sierra Leone
- Sur
How they compare
Sierra Leone currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Sierra Leone's figure about 1.2 times Sur's.
The two have swapped places 3 times across 16 shared years of data; in 2009 it was Sur ahead.
Sierra Leone ranks 1st and Sur ranks 2nd of 144 countries.
Across the 3 decades both report, Sierra Leone averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Sierra Leone | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 50.0% | 37.0% | Sur |
| 2010s | 69.6% | 66.3% | 3.3% | Sierra Leone |
| 2020s | 100.0% | 75.8% | 24.2% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sierra Leone or Sur?
- Sierra Leone, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sierra Leone and Sur?
- 18.0%, with Sierra Leone ahead.
- How many years of comparable data are there for Sierra Leone and Sur?
- 16 years are reported by both, from 2009 to 2024.
- How do Sierra Leone and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sierra Leone ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.